Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)—insights of people affected by cancer and healthcare professionals: a qualitative study protocol

Stephen Jennings; Sally Anstey; Janet Bower; Alison Brewster; John Buckman; Deborah Fenlon; Deborah Fitzsimmons; Tessa Watts

doi:10.1136/bmjopen-2020-043750

Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)—insights of people affected by cancer and healthcare professionals: a qualitative study protocol

Stephen Jennings
, Sally Anstey
, Janet Bower
, Alison Brewster
, John Buckman
, Deborah Fenlon
, Deborah Fitzsimmons
, Tessa Watts

Bristol Medical School (THS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

7 Citations (Scopus)

77 Downloads (Pure)

Original language	English
Article number	bmjopen-2020-043750
Journal	BMJ Open
Volume	11
Issue number	5
DOIs	https://doi.org/10.1136/bmjopen-2020-043750
Publication status	Published - 27 May 2021

Bibliographical note

Funding Information:
Funding This study was supported by Macmillan Cancer Support (FO = 7165318).

Publisher Copyright:
© Author(s) (or their employer(s)) 2021.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1136/bmjopen-2020-043750Licence: CC BY-NC

Full-text PDF (final published version)
This is the final published version of the article (version of record). It first appeared online via BMJ at https://doi.org/10.1136/bmjopen-2020-043750 . Please refer to any applicable terms of use of the publisher.
Final published version, 543 KBLicence: CC BY-NC

Handle.net

Persistent link

Cite this

Jennings, S., Anstey, S., Bower, J., Brewster, A., Buckman, J., Fenlon, D., Fitzsimmons, D., & Watts, T. (2021). Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)—insights of people affected by cancer and healthcare professionals: a qualitative study protocol. BMJ Open, 11(5), Article bmjopen-2020-043750. https://doi.org/10.1136/bmjopen-2020-043750

@article{df0f62fc1a614845b42a4d13a617f01a,

title = "Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)—insights of people affected by cancer and healthcare professionals: a qualitative study protocol",

author = "Stephen Jennings and Sally Anstey and Janet Bower and Alison Brewster and John Buckman and Deborah Fenlon and Deborah Fitzsimmons and Tessa Watts",

note = "Funding Information: Funding This study was supported by Macmillan Cancer Support (FO = 7165318). Publisher Copyright: {\textcopyright} Author(s) (or their employer(s)) 2021.",

year = "2021",

month = may,

day = "27",

doi = "10.1136/bmjopen-2020-043750",

language = "English",

volume = "11",

journal = "BMJ Open",

issn = "2044-6055",

publisher = "BMJ Publishing Group",

number = "5",

}

Jennings, S, Anstey, S, Bower, J, Brewster, A, Buckman, J, Fenlon, D, Fitzsimmons, D & Watts, T 2021, 'Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)—insights of people affected by cancer and healthcare professionals: a qualitative study protocol', BMJ Open, vol. 11, no. 5, bmjopen-2020-043750. https://doi.org/10.1136/bmjopen-2020-043750

Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)—insights of people affected by cancer and healthcare professionals: a qualitative study protocol. / Jennings, Stephen; Anstey, Sally; Bower, Janet et al.
In: BMJ Open, Vol. 11, No. 5, bmjopen-2020-043750, 27.05.2021.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)—insights of people affected by cancer and healthcare professionals: a qualitative study protocol

AU - Jennings, Stephen

AU - Anstey, Sally

AU - Bower, Janet

AU - Brewster, Alison

AU - Buckman, John

AU - Fenlon, Deborah

AU - Fitzsimmons, Deborah

AU - Watts, Tessa

PY - 2021/5/27

Y1 - 2021/5/27

UR - https://doi.org/10.1136/bmjopen-2020-043750

U2 - 10.1136/bmjopen-2020-043750

DO - 10.1136/bmjopen-2020-043750

M3 - Article (Academic Journal)

C2 - 34045214

SN - 2044-6055

VL - 11

JO - BMJ Open

JF - BMJ Open

IS - 5

M1 - bmjopen-2020-043750

ER -

Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)—insights of people affected by cancer and healthcare professionals: a qualitative study protocol

Bibliographical note

UN SDGs

Access to Document

Handle.net

Other files and links

Cite this